Issue 7, 2014

ω-Heteroarylalkylcarbamates as inhibitors of fatty acid amide hydrolase (FAAH)

Abstract

Fatty acid amide hydrolase (FAAH) is a serine hydrolase that terminates the analgetic and anti-inflammatory effects of endocannabinoids such as anandamide. Herein we describe structure–activity relationship studies on a new series of ω-heteroarylalkylcarbamate inhibitors of FAAH. The most active compounds exhibit IC50 values in the low nanomolar range. Investigations on selectivity and metabolic stability of these inhibitors are also presented.

Graphical abstract: ω-Heteroarylalkylcarbamates as inhibitors of fatty acid amide hydrolase (FAAH)

Supplementary files

Article information

Article type
Concise Article
Submitted
22 Apr 2014
Accepted
15 May 2014
First published
16 May 2014
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2014,5, 932-936

Author version available

ω-Heteroarylalkylcarbamates as inhibitors of fatty acid amide hydrolase (FAAH)

T. Terwege, H. Dahlhaus, W. Hanekamp and M. Lehr, Med. Chem. Commun., 2014, 5, 932 DOI: 10.1039/C4MD00181H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements